Abstract
Impact of Daptomycin Minimum Inhibitory Concentration (MIC) on Outcomes of Patients with Hematologic Malignancies and Hematopoietic Stem Cell Transplant (HSCT) Recipients with Vancomycin-Resistant Enterococci (VRE) Bloodstream Infection (BSI) Pearlie P. Chong , David van Duin , Ananta Bangdiwala , Anastasia Ivanova , Alan Kerr , David J. Weber , Peter H. Gilligan , Tippu Khan , Thomas C. Shea . 1 Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC; 2 Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC; 3 Clinical Microbiology/Immunology, McLendon Clinical Laboratories, University of North Carolina Hospitals, Chapel Hill, NC; 4 Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC; 5 Department of Pharmacy, University of North Carolina, Chapel Hill, NC; 6 Bone Marrow Transplant Program, Division of Medical Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
